Clinical Trial Update: The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

View source ↗

Summary

The ROLFH study investigating regression of liver fibrosis and risk for hepatocellular carcinoma in chronic hepatitis C and chronic hepatitis B patients has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C

Snippet

Sponsor: University of Arkansas | Conditions: Chronic Hepatitis C, Chronic Hepatitis B | Status: WITHDRAWN